New combination therapy developed for multiple myeloma
Each year, more than 25,000 Americans are diagnosed with multiple myeloma, a form of blood cancer that often develops resistance to therapies. However, researchers at Virginia Commonwealth University Massey Cancer Center are reporting promising results from laboratory experiments testing a new combination therapy that could potentially overcome the resistance hurdle.
And the award goes to…
Once again, numerous VCU Massey Cancer Center physicians were recognized as “Top Docs” in Richmond Magazine’s April 2014 issue. The list included 20 doctors from multiple specialties who provide care to Massey’s patients. The selections were the result of a survey that asked Richmond-area physicians who they would recommend in a range of specialties. The following Massey physicians were named as top performers in their respective categories.
Researchers uncover allergy-cancer connection
While many are stocking up on allergy medicine in preparation for spring, a new study from researchers at Virginia Commonwealth University Massey Cancer Center has uncovered a new connection between allergy and cancer that could potentially lead to therapies involving common antihistamines.
VCU welcomes new clinical research services executive director
Fredika A. Robertson, Ph.D., has joined Virginia Commonwealth University as its new executive director of Clinical Research Services (CRS) for the Center for Clinical and Translational Research (CCTR). She is also a professor in the Department of Internal Medicine in the VCU School of Medicine and a member of the Developmental Therapeutics research program at VCU Massey Cancer Center.
Massey on the Radio: Dr. Mark Malkin
Massey neuro-oncologist Mark G. Malkin, took to the airwaves recently to discuss his field and why he believes in the Massey difference.